USPTO serial 86823250
JYMED PEPTIDE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 2, 2019
- Examiner
- GARCIA, CLAUDIA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.
Need help with JYMED PEPTIDE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Shenzhen JYMed Technology Co., Ltd.
Nanshan, Shenzhen, CN
Other trademarks owned by Shenzhen JYMed Technology Co., Ltd.
Shenzhen JYMed Technology Co., Ltd.
Shenzhen,Pingshan Dist, CN
Other trademarks owned by Shenzhen JYMed Technology Co., Ltd.
Shenzhen JYMed Technology Co., Ltd.
Shenzhen,Pingshan Dist, CN
Other trademarks owned by Shenzhen JYMed Technology Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy T. Wang
Timothy T. Wang NI WANG & MASSAND PLLC8140 WALNUT HILL LN STE 615DALLAS, TX 75231United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection containing peptides; Pharmaceutical preparations for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection containing peptides; Drugs for medical purposes, namely, drugs for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection containing peptides; Active synthetic peptides used for the prevention and treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection; Nutritional supplements containing peptides; Veterinary preparations, namely, pain relief medication containing peptides; Veterinary preparations for treatment of intestinal bacteria, parasite, infectious diseases, digestive system disease, respiratory disease, reproductive diseases containing peptides; Biological preparations for veterinary purposes, namely, for domestic animals and livestock for the prevention and treatment of infectious diseases, bacterial infections, hypertension, cardiovascular disease, urinary infections, renal disease, reproductive diseases containing peptides; Dietary supplements for animals containing peptides | ACTIVE | Jul 21, 2016 |
| 035 | [ Advertising; Medical supplies retail store and wholesale distributorship services; Business management and organization consulting; Providing an online market of goods and services for buyers and sellers; Sales promotion for others; Import-export agencies; Retail store and wholesale distributorship services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Systemization of information into computer databases; Drug retail store and wholesale distributorship services; Veterinary drug retail store and wholesale distributorship services ] | SECTION 8 - CANCELLED | May 9, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Shenzhen JYMed Technology Co., Ltd.
- Other trademarks owned by Shenzhen JYMed Technology Co., Ltd.
- Other trademarks owned by Shenzhen JYMed Technology Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named JYMED PEPTIDE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 26, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Apr 26, 2025 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Apr 26, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 7, 2024 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Apr 2, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 2, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 27, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Feb 26, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Feb 15, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Feb 14, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 24, 2019 | IUAF | USE AMENDMENT FILED | — |
| Jan 24, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 25, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 13, 2018 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Nov 13, 2018 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Nov 13, 2018 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Apr 30, 2018 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 30, 2018 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 27, 2018 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Nov 22, 2017 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 31, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 31, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 11, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 26, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 25, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 12, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 6, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 6, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 6, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 6, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 11, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 8, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 23, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 1, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 7, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 24, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 23, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 23, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 23, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 23, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 1, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 12, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 12, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 12, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 14, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 1, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 31, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 14, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2015 | NWAP | NEW APPLICATION ENTERED | — |